Paper3299709
Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
Hoffman SL and 8 others. Science, 1987. Cited by 203 papers, by iCite.
Cite this record
ConductScience Library. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Papers, record 3299709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3299709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Antigens, Surface | Major topic |
| Malaria | Major topic |
| Plasmodium falciparum | Major topic |
| Protozoan Proteins | Major topic |
| Vaccines | Major topic |
| Adult | |
| Antigens, Protozoan | |
| Humans | |
| Kenya | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Spores | |
| Time Factors |
Source PubMed
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42606125 | Monoclonal antibody CIS43LS sets the bar for long-acting malaria protection. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42606125 | PubMed |
| 41030440 | Controlled human malaria infection with NF54 and 7G8 strains elicit differential antibody responses to Plasmodium falciparum peptides. | Front Immunol | 2025 | https://conductscience.org/library/papers/41030440 | PubMed |
| 38890271 | Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms. | Nat Commun | 2024 | https://conductscience.org/library/papers/38890271 | PubMed |
| 37571809 | Sporozoite immunization: innovative translational science to support the fight against malaria. | Expert Rev Vaccines | 2023 | https://conductscience.org/library/papers/37571809 | PubMed |
| 37198702 | Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects. | Trop Med Health | 2023 | https://conductscience.org/library/papers/37198702 | PubMed |
| 34033654 | Whole-genome analysis of Malawian Plasmodium falciparum isolates identifies possible targets of allele-specific immunity to clinical malaria. | PLoS Genet | 2021 | https://conductscience.org/library/papers/34033654 | PubMed |
| 33737844 | Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough? | Risk Manag Healthc Policy | 2021 | https://conductscience.org/library/papers/33737844 | PubMed |
| 33363057 | Accelerator or Brake: Immune Regulators in Malaria. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33363057 | PubMed |
| 33124533 | Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/33124533 | PubMed |
| 32435704 | Future use-cases of vaccines in malaria control and elimination. | Parasite Epidemiol Control | 2020 | https://conductscience.org/library/papers/32435704 | PubMed |
| 32415811 | OMIP-064: A 27-Color Flow Cytometry Panel to Detect and Characterize Human NK Cells and Other Innate Lymphoid Cell Subsets, MAIT Cells, and γδ T Cells. | Cytometry A | 2020 | https://conductscience.org/library/papers/32415811 | PubMed |
| 32181490 | Complement in malaria: immune evasion strategies and role in protective immunity. | FEBS Lett | 2020 | https://conductscience.org/library/papers/32181490 | PubMed |
| 31556468 | Complement in malaria immunity and vaccines. | Immunol Rev | 2020 | https://conductscience.org/library/papers/31556468 | PubMed |
| 31462718 | Antibodies against Plasmodium falciparum malaria at the molecular level. | Nat Rev Immunol | 2019 | https://conductscience.org/library/papers/31462718 | PubMed |
| 31402382 | Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31402382 | PubMed |
| 30828645 | Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso. | Wellcome Open Res | 2018 | https://conductscience.org/library/papers/30828645 | PubMed |
| 29706136 | Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children. | BMC Med | 2018 | https://conductscience.org/library/papers/29706136 | PubMed |
| 29554084 | A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein. | Nat Med | 2018 | https://conductscience.org/library/papers/29554084 | PubMed |
| 29438525 | Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29438525 | PubMed |
| 28620385 | The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications. | Front Immunol | 2017 | https://conductscience.org/library/papers/28620385 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3299709
GET https://conductscience.org/api/papers/v1/3299709/cited_by?page=2